Cancer
The Society for Cellular Pathology Scientists of Nigeria (SCPSN) has emphasized the importance of adopting genomic testing for improved cancer diagnosis, treatment, and prevention. At the eighth International Scientific Conference/Annual General Meeting of the association in Lagos, the National President, Dr Jonathan Madukwe, called for the adoption of genomic
Cancer
Researchers at the SRM Institute of Science and Technology have made a significant breakthrough in cancer detection using an artificial intelligence-powered terahertz metasurface biosensor. The sensor utilizes a unique combination of materials, including graphene, magnesium oxide, and calcium fluoride, to detect minute changes in the refractive index of biomarkers associated
Cancer
Shanghai Henlius Biotech, a leading biopharmaceutical company, has announced the initiation of a phase 3 clinical trial for the treatment of gastroesophageal junction and gastric cancer in the United States. The trial, which is also ongoing in mainland China, Australia, Japan, and other countries, aims to evaluate the efficacy and
Cancer
The COVID-19 pandemic accelerated the adoption of telemedicine, but its effects on the time burden of interacting with the healthcare system among advanced cancer patients remain unclear. A recent study published in the JAMA Network Open aimed to evaluate the association of the pandemic with time toxicity for patients with
Cancer
Former Sky News presenter Dermot Murnaghan, now 67, has shared his distressing experience of being diagnosed with stage four prostate cancer, which he believes could have been caught earlier if he had undergone more frequent PSA blood tests. The alarming diagnosis has become a "massive wake-up call" for
Cancer
A new report published in the journal Epidemiology, Biostatistics and Public Health presents a comprehensive review of gastric cancer treatment modalities and emerging therapies. Researchers at Wenzhou Medical University conducted a systematic review of existing literature and identified promising outcomes for laparoscopic gastrectomy and other minimally invasive surgical approaches. The
Cancer
Researchers at Indiana University School of Medicine have discovered a potential new approach to combat acute myeloid leukemia, a fatal and aggressive form of blood cancer, by targeting both cancer cells and their protective environment. The study's findings, published in Nature Communications, focus on the role of leukemia
Cancer
A recent study by researchers from the First Affiliated Hospital of Nanjing Medical University has highlighted the importance of noninvasive imaging technologies in the early diagnosis and monitoring of cancer therapy-related cardiovascular toxicity (CTR-CVT) in tumor patients. According to the research, cardiovascular damage caused by cancer treatment has become a
Cancer
Steve Visco, a retired Air Force colonel, was given a shocking diagnosis of advanced cancer by his oncologist in 2023. However, his claim for disability through the Department of Veterans Affairs (VA) had been approved but rated at 0%, leading him to suspect a mistake. With the help of DAV
Cancer
Researchers from Beijing Normal University have made a significant advancement in cancer gene therapy with the design of a versatile block polyester vector, BFN2. This innovative nanoplatform combines the benefits of photodynamic therapy and targeted gene silencing, effectively overcoming the limitations of each individual approach. According to the study, the
Cancer
A new study published in Acta Pharmaceutica Sinica B has made significant strides in cancer gene therapy. Researchers from the College of Pulmonary and Critical Care Medicine, Chinese People's Liberation Army (PLA) General Hospital, have developed submicron-sized biomimetic liposomes that effectively target and treat metastatic lung cancer. The
Cancer
Recent research conducted at the Ohio State University suggests that screening for depression and initiating appropriate therapy may improve surgical outcomes among patients with abdominal cancer and comorbid depression. The study, which analyzed data from a large cohort of patients diagnosed with hepatobiliary, pancreatic, and colorectal cancers between 2008 and
